Caas Capital Management LP Omeros Corp Transaction History

Caas Capital Management LP

  • $895 Million
  • Q1 2025

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 17, 2021
SELL
$14.52 - $23.53 $290,617 - $470,952
-20,015 Closed
0 $0
Q4 2020

Feb 12, 2021
SELL
$10.14 - $15.19 $455,874 - $682,912
-44,958 Reduced 69.19%
20,015 $286,000
Q3 2020

Nov 09, 2020
BUY
$9.57 - $21.32 $621,791 - $1.39 Million
64,973 New
64,973 $657,000

Others Institutions Holding OMER

# of Institutions
155
Shares Held
33.1M
Call Options Held
2.2M
Put Options Held
2.72M
View Full List

About OMEROS CORP

OMER Quotes by TradingView
  • Ticker OMER
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,730,000
  • Market Cap $465M
  • Description
  • Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...
More about OMER
Track This Portfolio

Track Caas Capital Management LP Portfolio

Follow Caas Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caas Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Caas Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email